Co-alteration of EGFR mutation and ALK rearrangement in non-small cell lung cancer: Case series

Lignende værker

• Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer
  af: Park, Cheol-Kyu, et al.
  Udgivet: (2019)
• Feasibility of re‐biopsy and EGFR mutation analysis in patients with non‐small cell lung cancer
  af: Kim, Tae‐Ok, et al.
  Udgivet: (2018)
• Delayed diagnosis of lung cancer due to misdiagnosis as worsening of sarcoidosis: a case report
  af: Shin, Hong-Joon, et al.
  Udgivet: (2020)
• Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR‐tyrosine kinase inhibitor treatment response
  af: Park, Ha Young, et al.
  Udgivet: (2016)
• Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression
  af: Park, Ha-Young, et al.
  Udgivet: (2019)